Warhead Library

Loading...
Target
Molecular Weight
to
Your selection
  • Your selection

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

Structure Catalog Product Name CAS Molecular Formula Molecular Weight Target Inquiry
1-[(3S)-3-[8-anilino-2-[4-(4-methylpiperazin-1-yl)anilino]purin-9-yl]pyrrolidin-1-yl]prop-2-en-1-one BPL-100122 1-[(3S)-3-[8-anilino-2-[4-(4-methylpiperazin-1-yl)anilino]purin-9-yl]pyrrolidin-1-yl]prop-2-en-1-one 2737283-18-8 C29H33N9O 523.64

EGFR
EGFR e19d
EGFR L858R/T790M

 Inquiry
1-[(3S)-3-[8-anilino-2-[4-(4-methylpiperazin-1-yl)anilino]purin-9-yl]piperidin-1-yl]prop-2-en-1-one BPL-100123 1-[(3S)-3-[8-anilino-2-[4-(4-methylpiperazin-1-yl)anilino]purin-9-yl]piperidin-1-yl]prop-2-en-1-one 2737283-20-2 C30H35N9O 537.67

EGFR
EGFR e19d
EGFR L858R/T790M

 Inquiry
1-[(3S)-3-[8-anilino-2-[4-(4-methylpiperazin-1-yl)anilino]purin-9-yl]piperidin-1-yl]propan-1-one BPL-100124 1-[(3S)-3-[8-anilino-2-[4-(4-methylpiperazin-1-yl)anilino]purin-9-yl]piperidin-1-yl]propan-1-one 2768472-25-7 C30H37N9O 539.69

EGFR
EGFR e19d
EGFR L858R/T790M

 Inquiry
i4EG-BiP BPL-100125 i4EG-BiP 1601469-08-2 C24H18N4O4S 458.49

eIF4E

 Inquiry
AT7519-7 BPL-100126 AT7519-7 844441-83-4 C17H18F2N4O3 364.35

CDK2

 Inquiry
PLK1/BRD4-IN-1 BPL-100127 PLK1/BRD4-IN-1 2412707-81-2 C31H43N9O2 573.73

BRD4

 Inquiry
Description: PLK1/BRD4-IN-1 is an orally active dual PLK1 and BRD4 inhibitor with IC50 values of 22 nM and 109 nM against PLK1 and BRD4, respectively. It induces cell cycle arrest and apoptosis, downregulates the transcription of several proliferation-related oncogenes, and exhibits favorable in vivo antitumor activity.
ethyl 3-[2-(tert-butylamino)-1-[formyl-[(3,4,5-trifluorophenyl)methyl]amino]-2-oxoethyl]-6-chloro-1H-indole-2-carboxylate BPL-100128 ethyl 3-[2-(tert-butylamino)-1-[formyl-[(3,4,5-trifluorophenyl)methyl]amino]-2-oxoethyl]-6-chloro-1H-indole-2-carboxylate 1356578-21-6 C25H25ClF3N3O4 523.94

MDM2

 Inquiry
(Z)-2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-2-(cyanomethyl)piperazine-1-carbonyl]-3-cyclopropylprop-2-enenitrile BPL-100129 (Z)-2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-2-(cyanomethyl)piperazine-1-carbonyl]-3-cyclopropylprop-2-enenitrile C36H39ClN8O2 651.21

KRAS G12C

 Inquiry
2-[[5-(2-chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]acetic acid BPL-100130 2-[[5-(2-chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]acetic acid 2653336-02-6 C21H15ClN4O4 422.83

BTK

 Inquiry
(4-((cis-4-aminocyclohexyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)(2-chloro-4-phenoxyphenyl)methanone BPL-100131 (4-((cis-4-aminocyclohexyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)(2-chloro-4-phenoxyphenyl)methanone 2653336-16-2 C25H24ClN5O2 461.95

BTK

 Inquiry
N-hydroxy-4-[(E)-[(2Z)-2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-ylidene]amino]oxybutanamide BPL-100132 N-hydroxy-4-[(E)-[(2Z)-2-(2-oxo-1H-indol-3-ylidene)-1H-indol-3-ylidene]amino]oxybutanamide 2762181-73-5 C20H18N4O4 378.39

HDAC6

 Inquiry
TRE-069 BPL-100133 TRE-069 2154370-25-7 C23H27ClN6O3S 503.02

EGFR
EGFR del19/T790M
EGFR del19/T790M/C797S
EGFR e19d

 Inquiry
SI-191 BPL-100134 SI-191 2754428-37-8 C40H44N7O10P 813.80

STAT3

 Inquiry
GTPL10702 BPL-100135 GTPL10702 2412753-91-2 C28H28F2N8O4S 610.63

PI3Kalpha

 Inquiry
1-[4-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea BPL-100136 1-[4-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea 2304798-90-9 C20H21N7O2 391.43

FLT3

 Inquiry
BMS-37 BPL-100137 BMS-37 1675202-20-6 C27H32N2O4 448.56

PD-L1

 Inquiry
Description: BMS-37 is a novel inhibitor of PD-1/PD-L1 immune checkpoint.
N-hydroxy-3-[4-(phenylsulfanylmethyl)triazol-1-yl]benzamide BPL-100138 N-hydroxy-3-[4-(phenylsulfanylmethyl)triazol-1-yl]benzamide 1600528-07-1 C16H14N4O2S 326.37

HDAC8

 Inquiry
Formohydroxamic acid BPL-100139 Formohydroxamic acid 4312-87-2 CH3NO2 61.04

HDAC1
HDAC3
HDAC6

 Inquiry
2-Aminoformanilide BPL-100141 2-Aminoformanilide 34840-28-3 C7H8N2O 136.15

HDAC1
HDAC3
HDAC6

 Inquiry
2-[[4-(4-acetyl-1,4-diazepan-1-yl)-6-(2-thiophen-2-ylethylamino)-1,3,5-triazin-2-yl]-methylamino]acetic acid BPL-100142 2-[[4-(4-acetyl-1,4-diazepan-1-yl)-6-(2-thiophen-2-ylethylamino)-1,3,5-triazin-2-yl]-methylamino]acetic acid 2417159-58-9 C19H27N7O3S 433.53

Tau

 Inquiry

* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket
Loading ......
Delete selectedGo to checkout